An Orthotopic Model of Pancreatic Somatostatin Receptor (SSTR)-Positive Tumors Allows Bimodal Imaging Studies Using 3T MRI and Animal PET-Based Molecular Imaging of SSTR Expression

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Neuroendocrinology

• Publication date

  2007-11-16

• Fields of study

  Biology, Medicine, Engineering

• Identifiers
  DOI 10.1159/000111502PMID 18025811
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Murine models to evaluate novel and conventional therapeutic strategies for cancer.

  2007cited by this paper
• Multimodality imaging of tumor xenografts and metastases in mice with combined small-animal PET, small-animal CT, and bioluminescence imaging.

  2007cited by this paper
• Molecular imaging of gastrin-releasing peptide receptor-positive tumors in mice using 64Cu- and 86Y-DOTA-(Pro1,Tyr4)-bombesin(1-14).

  2007cited by this paper
• 18F-labeled bombesin analogs for targeting GRP receptor-expressing prostate cancer.

  2006cited by this paper
• Comparison of the pharmacokinetics of 68Ga-DOTATOC and [18F]FDG in patients with metastatic neuroendocrine tumours scheduled for 90Y-DOTATOC therapy

  2006cited by this paper
• Quantitative assessment of SSTR2 expression in patients with non-small cell lung cancer using68Ga-DOTATOC PET and comparison with18F-FDG PET

  2006cited by this paper
• Successful high-resolution animal positron emission tomography of human Ewing tumours and their metastases in a murine xenograft model

  2006cited by this paper
• Mouse models in oncogenesis and cancer therapy

  2006cited by this paper
• The present and future role of (111)In pentetreotide in the PET era.

  2005cited by this paper
• Treatment with 177Lu-DOTATOC of patients with relapse of neuroendocrine tumors after treatment with 90Y-DOTATOC.

  2005cited by this paper
• Combination radionuclide therapy using 177Lu- and 90Y-labeled somatostatin analogs.

  2005cited by this paper
• 68Ga-DOTANOC: a first compound for PET imaging with high affinity for somatostatin receptor subtypes 2 and 5

  2005cited by this paper
• Quantitative immuno-positron emission tomography imaging of HER2-positive tumor xenografts with an iodine-124 labeled anti-HER2 diabody.

  2005cited by this paper
• Endocrine tumours of the gastrointestinal tract. Management of metastatic endocrine tumours.

  2005cited by this paper
• Management of metastatic endocrine tumours

  2005cited by this paper
• Tumour Biology of Gastroenteropancreatic Neuroendocrine Tumours

  2004cited by this paper
• First (18)F-labeled tracer suitable for routine clinical imaging of sst receptor-expressing tumors using positron emission tomography.

  2004cited by this paper
• Proof of principle for the use of 11C-labelled peptides in tumour diagnosis with PET

  2004cited by this paper
• Somatostatin and Other Peptide Receptors as Tools for Tumor Diagnosis and Treatment

  2004cited by this paper
• Importance of orthotopic implantation for human tumors as model systems: relevance to metastasis and invasion

  2004cited by this paper
• Feasibility of somatostatin receptor scintigraphy in the detection of occult primary gastro-entero-pancreatic (GEP) neuroendocrine tumours

  2004cited by this paper
• First 18F-Labeled Tracer Suitable for Routine Clinical Imaging of sst Receptor-Expressing Tumors Using Positron Emission Tomography

  2004cited by this paper
• Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS).

  2004cited by this paper
• DOTA-NOC, a high-affinity ligand of somatostatin receptor subtypes 2, 3 and 5 for labelling with various radiometals

  2003cited by this paper
• Evaluation of positron emission tomography imaging using [68Ga]-DOTA-D Phe(1)-Tyr(3)-Octreotide in comparison to [111In]-DTPAOC SPECT. First results in patients with neuroendocrine tumors.

  2003cited by this paper
• Expression of chromogranin A and somatostatin receptors in pancreatic AR42J cells.

  2002cited by this paper
• Ga-66 labeled somatostatin analogue DOTA-DPhe1-Tyr3-octreotide as a potential agent for positron emission tomography imaging and receptor mediated internal radiotherapy of somatostatin receptor positive tumors.

  2002cited by this paper
• The clinical role of somatostatin analogues as antineoplastic agents: much ado about nothing?

  2002cited by this paper
• NODAGATOC, a new chelator-coupled somatostatin analogue labeled with [67/68Ga] and [111In] for SPECT, PET, and targeted therapeutic applications of somatostatin receptor (hsst2) expressing tumors.

  2002cited by this paper
• Neuroendocrine tumor targeting: Study of novel gallium‐labeled somatostatin radiopeptides in a rat pancreatic tumor model

  2002cited by this paper
• Biokinetics and imaging with the somatostatin receptor PET radioligand 68Ga-DOTATOC: preliminary data

  2001cited by this paper
• An Orthotopic Model of Ductal Adenocarcinoma of the Pancreas in Severe Combined Immunodeficient Mice Representing All Steps of the Metastatic Cascade

  2001cited by this paper
• Biokinetics of 111In-DTPA-D-Phe(1)-octreotide in nude mice transplanted with a human carcinoid tumor.

  2001cited by this paper
• Receptor-targeted optical imaging of tumors with near-infrared fluorescent ligands

  2001cited by this paper
• Affinity profiles for human somatostatin receptor subtypes SST1–SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use

  2000cited by this paper
• Gastrointestinal Endocrinology

  1999cited by this paper
• What is the Optimal Rodent Model for Anti-tumor Drug Testing?

  1998cited by this paper
• Comparison of somatostatin receptor imaging, computed tomography and ultrasound in the clinical management of neuroendocrine gastro-entero-pancreatic tumours

  1998cited by this paper
• Chromogranin A: its clinical value as marker of neuroendocrine tumours

  1998cited by this paper
• Distribution of somatostatin receptors in normal and neoplastic human tissues: recent advances and potential relevance.

  1997cited by this paper
• Immunohistochemical localization of chromostatin and pancreastatin, chromogranin A-Derived bioactive peptides, in normal and neoplastic neuroendocrine tissues

  1995cited by this paper
• Evaluation of technetium-99m-triamide-mercaptide complexes designed to identify properties favoring renal tubular transport.

  1994cited by this paper
• Detection of somatostatin receptor subtype 2 (SSTR2) in established tumors and tumor cell lines: evidence for SSTR2 heterogeneity.

  1994cited by this paper
• An interactive technique for three-dimensional image registration: validation for PET, SPECT, MRI and CT brain studies.

  1994cited by this paper
• Studies of growth regulation in a neuroendocrine cell line.

  1993cited by this paper
• An amphicrine pancreatic cell line: AR42J cells combine exocrine and neuroendocrine properties.

  1992cited by this paper
• Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract, and kidney.

  1992cited by this paper
• Synaptophysin. A widespread constituent of small neuroendocrine vesicles and a new tool in tumor diagnosis.

  1991cited by this paper
• Distribution of somatostatin receptors in normal and tumor tissue.

  1990cited by this paper

• Survival impact of [225Ac]Ac-DOTATOC alpha-therapy in a preclinical model of pancreatic neuroendocrine tumor liver micrometastases

  2024cites this paper
• Distinctive detection of insulinoma using [18F]FB(ePEG12)12-exendin-4 PET/CT

  2021cites this paper
• In vivo monitoring of cancer specific TCR-engineered human T cells by Immuno-PET to analyze pharmacokinetics of T-cell based immunotherapies

  2016cites this paper
• 68Ga-DOTATOC and FDG PET Imaging of Preclinical Neuroblastoma Models.

  2016cites this paper
• Immuno-PET Imaging of Engineered Human T Cells in Tumors.

  2016cites this paper
• Image fusion combining SEM and ToF‐SIMS images

  2015cites this paper
• Multimodale molekulare Bildgebung solider Tumore im Mausmodell

  2015cites this paper
• Imaging preclinical tumour models: improving translational power

  2014cites this paper
• Targeting Aurora Kinases with Danusertib (PHA-739358) Inhibits Growth of Liver Metastases from Gastroenteropancreatic Neuroendocrine Tumors in an Orthotopic Xenograft Model

  2012cites this paper
• Neuroendocrine Tumors in an Orthotopic Xenograft Model Growth of Liver Metastases from Gastroenteropancreatic Targeting Aurora Kinases with Danusertib (PHA-739358) Inhibits

  2012cites this paper
• Animal models and molecular imaging tools to investigate lymph node metastases

  2011cites this paper
• Models for Evaluation of Targeted Therapies of Invasive and Metastatic Disease

  2011cites this paper
• Small animal tumour imaging with MRI and the ECAT EXACT scanner: application of partial volume correction and comparison with microPET data

  2010cites this paper
• 2 Murine L 1210 and P 388 Leukemias

  2010cites this paper
• Experimentelle Kleintier-MRT: Klinische MRT-Systeme als Schnittstelle zur biomedizinischen Grundlagenforschung

  2008cites this paper